Literature DB >> 19302264

Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet.

A Lanzini1, F Lanzarotto, V Villanacci, A Mora, S Bertolazzi, D Turini, G Carella, A Malagoli, G Ferrante, B M Cesana, C Ricci.   

Abstract

BACKGROUND: Expected benefits of gluten-free diet (GFD) in coeliac patients include healing of small intestinal mucosa, but it remains unclear to what extent this benefit is achieved in adults. AIM: To assess factors affecting histological outcome of GFD in a large cohort of adult coeliac patients.
METHODS: We extracted information on 465 consecutive coeliac patients studied before and during GFD.
RESULTS: Duodenal biopsies at diagnosis were classified as Marsh I in 11, II in 25 and III in 429 cases. After a median 16 months GFD, 38 (8%) patients had histological 'normalization', 300 (65%) had 'remission' with persistent intraepithelial lymphocytosis, 121(26%) had 'no change' and 6 (1%) had 'deterioration'. Coeliac disease related serology was negative in 83% of patients with Marsh III lesion during GFD. Male gender and adherence to GFD were independently associated with histological 'normalization' and 'remission'. Persistence of intraepithelial lymphocytosis was not associated with human lymphocyte antigen gene dose or with Helicobacter pylori infection.
CONCLUSIONS: Complete normalization of duodenal lesions is exceptionally rare in adult coeliac patients despite adherence to GFD, symptoms disappearance and negative CD related serology. Control biopsies are mandatory to identify lack of response to gluten-free diet.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302264     DOI: 10.1111/j.1365-2036.2009.03992.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  73 in total

1.  Capsule endoscopy in nonresponsive celiac disease.

Authors:  David S Atlas; Alberto Rubio-Tapia; Carol T Van Dyke; Brian D Lahr; Joseph A Murray
Journal:  Gastrointest Endosc       Date:  2011-08-11       Impact factor: 9.427

Review 2.  Quantitative image analysis of celiac disease.

Authors:  Edward J Ciaccio; Govind Bhagat; Suzanne K Lewis; Peter H Green
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

3.  Persistence of elevated deamidated gliadin peptide antibodies on a gluten-free diet indicates nonresponsive coeliac disease.

Authors:  B N Spatola; K Kaukinen; P Collin; M Mäki; M F Kagnoff; P S Daugherty
Journal:  Aliment Pharmacol Ther       Date:  2014-01-06       Impact factor: 8.171

4.  Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.

Authors:  Greetje J Tack; Jolanda M W van de Water; Maaike J Bruins; Engelina M C Kooy-Winkelaar; Jeroen van Bergen; Petra Bonnet; Anita C E Vreugdenhil; Ilma Korponay-Szabo; Luppo Edens; B Mary E von Blomberg; Marco W J Schreurs; Chris J Mulder; Frits Koning
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

5.  Recent advances in celiac disease.

Authors:  Hugh James Freeman; Angeli Chopra; Michael Tom Clandinin; Alan Br Thomson
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

6.  Predictors and Significance of Incomplete Mucosal Recovery in Celiac Disease After 1 Year on a Gluten-Free Diet.

Authors:  Henna Pekki; Kalle Kurppa; Markku Mäki; Heini Huhtala; Harri Sievänen; Kaija Laurila; Pekka Collin; Katri Kaukinen
Journal:  Am J Gastroenterol       Date:  2015-06-02       Impact factor: 10.864

7.  Small bowel carcinomas in celiac or Crohn's disease: distinctive histophenotypic, molecular and histogenetic patterns.

Authors:  Alessandro Vanoli; Antonio Di Sabatino; Michele Martino; Catherine Klersy; Federica Grillo; Claudia Mescoli; Gabriella Nesi; Umberto Volta; Daniele Fornino; Ombretta Luinetti; Paolo Fociani; Vincenzo Villanacci; Francesco P D'Armiento; Renato Cannizzaro; Giovanni Latella; Carolina Ciacci; Livia Biancone; Marco Paulli; Fausto Sessa; Massimo Rugge; Roberto Fiocca; Gino R Corazza; Enrico Solcia
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

8.  Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials.

Authors:  Matthew Siegel; Mitchell E Garber; Andrew G Spencer; Wendy Botwick; Pawan Kumar; Robert N Williams; Kenji Kozuka; Revati Shreeniwas; Vijaya Pratha; Daniel C Adelman
Journal:  Dig Dis Sci       Date:  2011-09-23       Impact factor: 3.199

9.  Persistent mucosal damage and risk of fracture in celiac disease.

Authors:  Benjamin Lebwohl; Karl Michaëlsson; Peter H R Green; Jonas F Ludvigsson
Journal:  J Clin Endocrinol Metab       Date:  2014-01-16       Impact factor: 5.958

10.  Is it gluten-free? Relationship between self-reported gluten-free diet adherence and knowledge of gluten content of foods.

Authors:  Jocelyn A Silvester; Dayna Weiten; Lesley A Graff; John R Walker; Donald R Duerksen
Journal:  Nutrition       Date:  2016-02-13       Impact factor: 4.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.